Æí¾ÈÇÑ ¹Ì¼Ò·Î ȯÀÚ¿Í ¼ÒÅëÇÏ´Â Àü¸³¼±¾Ï Àü¹®°¡
¼ÛÀ±¼· ±³¼ö´Â ÃÖ±Ù 3³â°£ Àü¸³¼±¾ÏÀÇ ¸¶ÀÌÅ©·Î¹ÙÀÌ ¿È, ¾Ï ´ë»ç, ¼¼Æ÷ ±â¹Ý À¯ÀüÀÚ Ä¡·á µî°ú °ü·ÃÇÑ 24ÆíÀÇ SCI ³í¹®À» ÁÖÀúÀÚ·Î ÃâÆÇÇß´Ù.
ÀÌµé ºÐ¾ß¸¦ Á¢¸ñÇÑ ³Ä¡¼º Àü¸³¼±¾Ï ¸é¿ª °ü¹® ¾ïÁ¦ ¾à¹° Ä¡·á¿¡ ´ëÇÑ ¿¬±¸¿¡ ¸ÅÁøÇϰí ÀÖ´Ù. 2024³â ´ëÇÑ ¹è´¢Àå¾Ö ¿ä½Ç±Ý ÇÐȸ Á¦29Â÷ Çмú´ëȸ ¹× Á¦18Â÷ ½Ç¹« ¿öÅ©¼ó¿¡¼ ¿ì¼ö³í¹®»óÀ» ¼ö»óÇϱ⵵ Çß´Ù. ºñ´¢ ÀÇÇаú ºÐ¾ß¿¡¼ Ȱ¹ßÇÑ ¿¬±¸ Ȱµ¿À» Çϸç ȯÀÚµéÀ» Ä¡·áÇϰí ÀÖÀ¸¸ç Çа迡¼µµ ÀÎÁ¤¹Þ°í ÀÖ´Ù.
Á¦ ¸ñ | The Correlations between the Intensity of Histopathological Ubiquitin-Specific Protease 11 Staining and Progression of Prostate Cancer | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2023 | ¹ßÇ¥Áö |
Á¦ ¸ñ | Carboxylesterase-overexpressing hTERT-immortalized human adipose stem cells in prostate tumor growth inhibition by irinotecan | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö |
Á¦ ¸ñ | Cytosine Deaminase-Overexpressing hTERT-Immortalized HumanAdiposeStemCells Enhance the Inhibitory Effects of Fluorocytosine on Tumor Growth in Castration Resistant Prostate Cancer | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö |
Á¦ ¸ñ | Different Prostatic Tissue Microbiomes between High- and Low-Grade Prostate Cancer Pathogenesis | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö |
Á¦ ¸ñ | The Positive Correlations between the Expression of Histopathological Ubiquitin-Conjugating Enzyme 2O Staining and Prostate Cancer Advancement | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2021 | ¹ßÇ¥Áö |
Á¦ ¸ñ | Malignant Prostate Tissue Is Associated with Different Microbiome Gene Functions | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2023 | ¹ßÇ¥Áö |
Á¦ ¸ñ | Biochemical Recurrence in Prostate Cancer Is Associated with the Composition of Lactobacillus: Microbiome Analysis of Prostatic Tissue | ||
---|---|---|---|
¹ßÇ¥³âµµ | 2023 | ¹ßÇ¥Áö |
³Ä¡¼º Àü¸³¼±¾ÏÀÇ Ä¡·á¸¦ À§ÇÏ¿© ¸é¿ª°ü¹®¾ïÁ¦¾à¹°, ¸¶ÀÌÅ©·Î¹ÙÀÌ¿È, ¼¼Æ÷±â¹Ý À¯ÀüÀÚ Ä¡·á ¿¬±¸ ºÐ¾ßÀ̸ç,ÀÓ»ó ÇöÀå¿¡¼ ÇØ°áµÇÁö ¸øÇß´ø ¹®Á¦¸¦ ÇØ°áÇϰí ÀÖÀ½.
ȯÀÚ¿¡°Ô Æí¾ÈÇÏ°í µµ¿òÀ̵Ǵ ÀÇ»çÀÌ°í ½Í´Ù.
ÃֽаúÇÐÀÇ ¹ßÀüÀ¸·Î Àü¿¡ ÇØ°áÇÏÁö ¸øÇß´ø ÁúȯÀ» »õ·Î¿î Ä¡·á¹ýÀÇ µîÀåÀ¸·Î ÇØ°áÇØ°¡°í ÀÖÀ¸´Ï ³¡±îÁö Èñ¹æÀ» ÀÒÁö¸»¶ó°í ¸»ÇÏ°í ½Í´Ù.
¼øÃµÇâ´ëÇб³¼¿ïº´¿øÀº 1974³â ÇÏ´ÃÀÇ ¶æÀ» ¹Þµé¾î ÀμúÀ» ÆîÃİ¡´Â °íÇ⸶À»À» ¸¸µé¾î °¡°Ú´Ù´Â Àΰ£»ç¶û, »ý¸íÁ¸ÁßÀÇ ¼øÃµÇâ(â÷ô¸úÁ) Á¤½ÅÀ¸·Î °³¿øÇß´Ù. 32°³ Áø·á°ú¿Í 700 º´»óÀ» ¿î¿µÇϸç 220¿©¸íÀÇ ±³¼ö¿Í 2õ¿©¸íÀÇ ±³Á÷¿øÀÌ Áø·á¿Í ¿¬±¸, ±³À°¿¡ ÃÖ¼±À» ´ÙÇϰí ÀÖ´Ù. Áö¿ª½É³úÇ÷°ü¼¾ÅÍ ÁöÁ¤, ÁßȯÀÚ½Ç È®Àå, ¾Ï½Å¼ÓÁö¿ø¼¾ÅÍ, CAR-TÄ¡·á µîÀ¸·Î ÁßÁõ Áø·á¸¦ °ÈÇϰí, ÀÇ·áÁúÆò°¡ 1µî±Þ, ÀÀ±ÞÀÇ·á±â°ü Æò°¡ Aµî±Þ, ȯÀÚ°æÇèÆò°¡ Àü±¹13À§¸¦ ºñ·ÔÇØ °¢Á¾ ÀûÁ¤¼ºÆò°¡ 1µî±ÞÀ» À¯ÁöÇÏ¸ç ¾ÈÀüÇÑ Áø·á·Î »çȸÀû Ã¥ÀÓ°ú °¡Ä¡¸¦ ±¸ÇöÇϰí ÀÖ´Ù.
¼¿ïƯº°½Ã ¿ë»ê±¸ ´ë»ç°ü·Î 59